Multisystem Inflammatory Syndrome (MIS) is an uncommon systemic illness that occurs 4-6 weeks after primary infection with SARS-CoV-2. There are emerging reports of MIS arising following vaccination against SARS-CoV-2. We report a 16-year-old male with a multi system inflammatory condition meeting the case definition for MIS following BTN162b2 mRNA SARS-CoV-2 (Pfizer BioNTech) vaccine with no other identifiable precipitant or evidence of primary infection with SARS-Cov-2.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843319 | PMC |
| http://dx.doi.org/10.1016/j.clinpr.2022.100139 | DOI Listing |
Publication Analysis
Top Keywords
inflammatory syndrome
8
16-year-old male
8
primary infection
8
infection sars-cov-2
8
multi inflammatory
4
syndrome 16-year-old
4
male dose
4
dose m-rna
4
m-rna covid-19
4
covid-19 vaccination
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!